Understanding Alagille Syndrome
At a Glance
Alagille Syndrome (ALGS) is a rare genetic disorder caused by JAG1 or NOTCH2 gene mutations. It affects multiple body systems, primarily the liver, heart, kidneys, and eyes. While symptoms vary, multidisciplinary medical care and treatments like IBAT inhibitors help manage the condition effectively.
Getting a diagnosis of Alagille Syndrome (ALGS) for your child can feel like the world has suddenly shifted. It is completely normal to feel overwhelmed, isolated, or even terrified. Because ALGS is a rare disease—occurring in approximately 1 in every 30,000 to 100,000 births [1][2]—you may find that your local pediatrician or family doctor has never treated a child with this condition before. This lack of familiarity can add to your anxiety, but it is a reflection of the condition’s rarity, not your child’s future [3].
ALGS is a multisystem disorder, meaning it can affect several different parts of the body, including the liver, heart, kidneys, and eyes [2][4]. While the diagnosis is a lot to process, understanding the “why” and “how” can help you regain a sense of control.
Understanding the Notch Signaling Pathway
To understand why ALGS affects so many different parts of the body, it helps to look at how a child’s body grows. Your child’s body uses a “communication system” called the Notch signaling pathway [5].
Think of this pathway like a series of vital text messages sent between neighboring cells during a baby’s development in the womb [6]. These messages tell the cells what they should become—for example, “You become a bile duct” or “You become part of the heart” [5]. In children with ALGS, there is a “glitch” in this messaging system, usually caused by a change in one of two genes: JAG1 (found in about 90% of cases) or NOTCH2 [7][5]. Because the “messages” don’t always get through correctly, some organs may not develop their full structure, such as having fewer bile ducts in the liver to carry waste away [8].
Three Stabilizing Facts
When you are in a “panic spiral,” it can be helpful to anchor yourself with facts that provide a clearer picture of the road ahead:
- Management is Highly Multidisciplinary: You are not expected to manage this alone. Because ALGS affects multiple systems, your child will be cared for by a team of specialists—including hepatologists (liver doctors), cardiologists (heart doctors), and nutritionists—who work together to monitor and treat symptoms [2][8].
- Symptoms Can Be Managed: Medical science has made significant strides in treating the most difficult symptoms of ALGS. For example, newer medications called IBAT inhibitors (such as maralixibat) have been shown to significantly reduce the intense itching (pruritus) that many children experience, greatly improving their quality of life [9][10].
- Variable Expressivity: This is a medical term meaning that the condition affects every person differently [11]. Even within the same family, one person might have very mild symptoms while another is more affected [12]. Your child’s journey is unique, and many children with ALGS lead full, active lives with the right medical support [13].
The Path Forward
In the coming weeks, your medical team will likely suggest “baseline” screenings. These are not signs that something is wrong, but rather a way to create a “map” of your child’s specific health needs. These may include an echocardiogram (an ultrasound of the heart), a kidney ultrasound, and a specialized eye exam to look for a harmless line in the eye called posterior embryotoxon, which is a common “marker” for ALGS but does not affect vision [14].
You are your child’s best advocate. While the diagnosis is rare, there is a dedicated community of experts and other parents walking this same path alongside you.
Common questions in this guide
What causes Alagille Syndrome?
Which organs are most affected by Alagille Syndrome?
Will every child with Alagille Syndrome have severe symptoms?
What medications are used to treat intense itching in ALGS?
What baseline tests are needed after an ALGS diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many children with Alagille Syndrome have you or this clinic managed in the past five years?
- 2.What is our child's specific genetic mutation, and does it help us understand what symptoms we should watch for most closely?
- 3.Which specialists (cardiology, nephrology, ophthalmology, etc.) should we see first for a baseline evaluation?
- 4.What is the plan for monitoring our child's liver function and screening for potential complications like vascular issues?
- 5.Who on our care team will be the 'lead' coordinator to help manage all the different specialist appointments?
- 6.Are there any specific medications, like maralixibat, that could help manage symptoms like itching?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Alagille syndrome and pregnancy.
Morton A, Kumar S
Obstetric medicine 2021; (14(1)):39-41 doi:10.1177/1753495X19849738.
PMID: 33995572 - 2
Alagille syndrome: an orphan disease in Colombia and summary of recent advances in treatment and survival - a case report.
Echeverri-Mejía C, Ríos-Orozco SU, Lozada-Martínez ID, Narvaez-Rojas AR
Annals of medicine and surgery (2012) 2023; (85(4)):1231-1234 doi:10.1097/MS9.0000000000000473.
PMID: 37113962 - 3
Childhood Cholestatic Liver Diseases that Persist Into Adulthood: Lessons for the Adult Gastroenterologist.
Chan AP, Venick RS
Journal of clinical gastroenterology 2023; (57(7)):686-693 doi:10.1097/MCG.0000000000001850.
PMID: 37022007 - 4
Alagille Syndrome.
Mitchell E, Gilbert M, Loomes KM
Clinics in liver disease 2018; (22(4)):625-641 doi:10.1016/j.cld.2018.06.001.
PMID: 30266153 - 5
Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment.
Kohut TJ, Gilbert MA, Loomes KM
Seminars in liver disease 2021; (41(4)):525-537 doi:10.1055/s-0041-1730951.
PMID: 34215014 - 6
Alagille Syndrome: An Overview.
Jesina D
Neonatal network : NN 2017; (36(6)):343-347 doi:10.1891/0730-0832.36.6.343.
PMID: 29185945 - 7
Isolated aneurysmal disease as an underestimated finding in individuals with JAG1 pathogenic variants.
Rodrigues Bento J, Krebsová A, Van Gucht I, et al.
Human mutation 2022; (43(12)):1824-1828 doi:10.1002/humu.24433.
PMID: 35819173 - 8
Jagged1 (JAG1): Structure, expression, and disease associations.
Grochowski CM, Loomes KM, Spinner NB
Gene 2016; (576(1 Pt 3)):381-4.
PMID: 26548814 - 9
Efficacy of ileal bile acid transport inhibitors in children with Alagille syndrome: a meta-analysis.
Lopes JR, Esteves IM, Libonati NB, et al.
European journal of pediatrics 2025; (184(12)):737 doi:10.1007/s00431-025-06576-w.
PMID: 41201627 - 10
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.
Gonzales E, Hardikar W, Stormon M, et al.
Lancet (London, England) 2021; (398(10311)):1581-1592 doi:10.1016/S0140-6736(21)01256-3.
PMID: 34755627 - 11
Defining pathogenicity of NOTCH2 variants for diagnosis of Alagille syndrome type 2 using a large cohort of patients.
Li ZD, Abuduxikuer K, Wang L, et al.
Liver international : official journal of the International Association for the Study of the Liver 2022; (42(8)):1836-1848 doi:10.1111/liv.15292.
PMID: 35567760 - 12
Two Novel Mutations in the JAG1 Gene in Pediatric Patients with Alagille Syndrome: The First Case Series in Czech Republic.
Prochazková D, Borská R, Fajkusová L, et al.
Diagnostics (Basel, Switzerland) 2021; (11(6)) doi:10.3390/diagnostics11060983.
PMID: 34071626 - 13
Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome.
Shneider BL, Spino CA, Kamath BM, et al.
Hepatology communications 2022; (6(8)):1922-1933 doi:10.1002/hep4.1992.
PMID: 35672955 - 14
Spectrum of cerebral arterial and venous abnormalities in Alagille syndrome.
Carpenter CD, Linscott LL, Leach JL, et al.
Pediatric radiology 2018; (48(4)):602-608 doi:10.1007/s00247-017-4043-2.
PMID: 29362841
This overview of Alagille Syndrome is for educational purposes only. Always consult your child's pediatric specialist or hepatologist for medical advice, diagnosis, and treatment planning.
Get notified when new evidence is published on Alagille syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.